Profarma Recalls 1% Clotrimazole Cream Due to Manufacturing Deviations
Profarma Distributors LLC is recalling 79 tubes of 1% Clotrimazole cream due to CGMP deviations. The recall is voluntary and nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to CGMP deviations, which typically indicates a remote probability of serious adverse health consequences or temporary/reversible effects, aligning with the Moderate severity criteria for low-risk contamination or voluntary precautionary recalls.
Plain-English summary
Profarma Distributors LLC is voluntarily recalling 79 boxes (79 tubes) of 1% Clotrimazole cream, 30 mg tube, UPC 501318644335. The affected product is identified by Lot # GRU1390 and an expiration date of 08/17. The recall was initiated on May 11, 2016, and was distributed nationwide.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. The FDA classified this recall as Class II, which indicates a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Consumers who have this product should stop using it and contact Profarma Distributors LLC for further instructions or a refund. The recall was terminated on January 24, 2017.
The recalled product
- Product
- 1% Clotrimazol cream, 30 mg tube, UPC 501318644335
- Manufacturer
- Profarma Distributors LLC
- Category
- Drug — Topical Antifungal
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # GRU1390
- Exp. 08/17
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Profarma Distributors LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Profarma Distributors LLC
See all →- ModerateProfarma Recalls Vermox Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2016-06-29
- ModerateProfarma Recalls tabcin ACTIVE M.R. Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2016-06-29
- ModerateProfarma Recalls Vermox Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2016-06-29
- ModerateProfarma Recalls tabcin NOCHE Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2016-06-29
Same hazard · cgmp deviations
See all →- SevereBaxter Recalls Famotidine Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateBaxter Recalls Pantoprazole Sodium Infusion Bags Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Nexterone Amiodarone Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Dexmedetomidine Hydrochloride Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateClotrimazole cream, 1 ounce size, recalled over good manufacturing practice deviations
FDA (Drugs) · 2025-12-10
- ModerateClotrimazole cream, 5 ounce size, recalled over good manufacturing practice deviations
FDA (Drugs) · 2025-12-10
- ModerateCura Hongos clotrimazole cream recalled over manufacturing practice deviations
FDA (Drugs) · 2026-06-24
- ModerateAlprazolam Tablets 1mg Recalled for CGMP Deviations
FDA (Drugs) · 2022-03-09
- ModeratePrescription Tadalafil tablets recalled for manufacturing process deviations
FDA (Drugs) · 2023-04-12
- HighClopidogrel Tablets 75 mg Recalled for Manufacturing Quality Deviations
FDA (Drugs) · 2023-04-12